Farallon Capital Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Farallon Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $222,840 - $388,919	6,000 New	6,000 $359,000
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $4.59 Million - $17.3 Million	194,053 New	194,053 $7.38 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $21.3 Million - $25.9 Million	-277,500 Reduced 87.39%	40,053 $3.65 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $6.19 Million - $8.9 Million	-132,847 Reduced 29.5%	317,553 $20.9 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $1.19 Million - $1.68 Million	-27,600 Reduced 5.77%	450,400 $23.3 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $21.4 Million - $33.3 Million	478,000 New	478,000 $32.6 Million
Q2 2021 Aug 13, 2021	SELL	$40.9 - $64.9 $25.6 Million - $40.6 Million	-625,000 Reduced 28.74%	1,550,000 $98 Million
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $4.08 Million - $5.74 Million	-100,000 Reduced 4.4%	2,175,000 $93.3 Million
Q3 2020 Nov 16, 2020	BUY	$25.89 - $33.65 $647,250 - $841,250	25,000 Added 1.11%	2,275,000 $68.6 Million
Q2 2020 Aug 14, 2020	BUY	$24.8 - $38.49 $6.2 Million - $9.62 Million	250,000 Added 12.5%	2,250,000 $73.5 Million
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $26.9 Million - $66.5 Million	1,500,000 Added 300.0%	2,000,000 $53.6 Million
Q4 2019 Feb 13, 2020	BUY	$22.1 - $30.8 $11.1 Million - $15.4 Million	500,000 New	500,000 $15.3 Million

302

112M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.19B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.